Bio-IT World Editors Named As Finalists In Prestigious Neal Editorial Excellence Awards

FRAMINGHAM, MA – JANUARY 24, 2003 – IDG's Bio-IT World, which launched in March, 2002, today announced that a total of eight members of its editorial team have been named as finalists in four major categories in this year's Jesse H. Neal National Business Journalism Awards competition, which recognize editorial excellence in independent business publications. Winners will be announced at an awards presentation on March 12 at The Waldorf-Astoria Hotel in New York City. Bio-IT World's editors were the only life sciences technology journalists to be recognized by American Business Media in this year's Neal Awards.


"Recognition in this prestigious, peer-judged industry competition is testament to the excellence of our editorial team, and their ability to examine complex scientific and technology topics within the context of the increasing impact of information-based technologies on life sciences research and development," said Dr. Morris Levitt, president and CEO, Bio-IT World, Inc.

American Business Media judges designated 81 entries as finalists, out of the total 1,093 entries received across eleven award categories in each of three revenue classes. Bio-IT World editors are finalists in the following categories:

Best Start-Up Publication (Class D, across all revenue categories): The Bio-IT World editorial team is recognized for delivering on its mission to help public and private life sciences organizations enhance their research, expedite drug discovery, and achieve cures for disease. Bio-IT World strives to achieve this mission by providing a rich combination of news, research and technological information vital to information technology professionals and biomedical researchers working at the intersection of IT and life science.

Best Single Article (Class A, up to $3 million in revenue): "Clinical Trial Data Management," August 2002 – Mark Uehling, senior science editor; Kevin Davies, editor in chief; John Russell, executive editor; Mark Gabrenya, art director. This article examines the inefficiencies associated with clinical drug trials, and how adoption of new technologies could save the industry millions of dollars.

Best Subject-Related Series of Articles (Class A, up to $3 million in revenue): "Pharmacogenomics," September and October 2002 – Malorye Branca, senior informatics editor; Kevin Davies, editor in chief; Mark Gabrenya, art director. This two-part series takes an in-depth look at the promises and failures of pharmacogenomics, the path to personalized medicine, and serves as a guide to help readers understand and capitalize on the trends shaping this emerging field.

Best Staff-Written Editorials on One or Several Subjects (Class A, up to $3 million in revenue): In his regular editorial columns, Editor in Chief Kevin Davies takes an informative, humorous, and sometimes provocative look at the critical issues confronting Bio-IT World's diverse readership of life scientists and IT professionals.

"These finalist designations are especially rewarding as we approach the first anniversary of the launch of Bio-IT World," said Dr. Kevin Davies, editor in chief, Bio-IT World. "As the only life sciences technology publication recognized in this year's Neal Awards, we are gratified to know that this peer-review process confirms the high quality of the stories and research we consistently deliver to our readers, many of whom are working on breakthrough cures for human disease."

Established in 1906, American Business Media is the industry association for business-to-business information providers. Its mission is to enhance knowledge and best practices of leading publishers and quality information providers for business, professional and specialized consumer markets worldwide. The Jesse H. Neal Editorial Achievement Awards were created by American Business Media in 1955 to recognize and reward editorial excellence in independent business publications covering every major industry and technology. The Neal Awards are presented annually to those editors who have submitted entries exhibiting journalistic enterprise, extent of service to the field, and editorial craftsmanship. For more information, visit

About Bio-IT World, Inc.

A business unit of IDG, Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT professionals. Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance. The company's premiere publication, Bio-IT World, and accompanying website,, deliver the latest news, analysis and information on the technology infrastructure and applications driving innovation in the bio-IT community. Established in September 2001, Bio-IT World, Inc. is headquartered in Framingham, Mass.

About IDG

Bio-IT World is a business unit of IDG, the world's leading technology media, research and event company. IDG publishes more than 300 magazines and newspapers and offers online users the largest network of technology-specific sites around the world through (, which comprises more than 330 targeted Web sites in 80 countries. IDG is also a leading producer of 168 computer-related events worldwide, and IDG's research company, IDC, provides global market intelligence and advice through 51 offices in 43 countries. Company information is available at


# # #